News & Updates

Amiselimod exhibits favourable safety in healthy individuals

27 Jan 2021 by

Amiselimod, an oral selective sphingosine 1-phosphate (S1P) receptor modulator, demonstrated a favourable safety profile among healthy individuals, according to a phase I study presented at Crohn’s and Colitis 2021.

Amiselimod exhibits favourable safety in healthy individuals

27 Jan 2021

Sexual problems in men with ankylosing spondylitis tied to disease activity

26 Jan 2021

Male patients with ankylosing spondylitis appear to have poor sexual performance, and this problem is associated with disease activity rather than sexual hormonal profile, according to a study.

Sexual problems in men with ankylosing spondylitis tied to disease activity

26 Jan 2021

Romilkimab shows potential for early diffuse cutaneous systemic sclerosis

22 Jan 2021 by

Romilkimab – a novel engineered, humanized immunoglobulin(Ig)-G4 antibody – delivers significant skin benefits for individuals with early diffuse cutaneous systemic sclerosis (dcSSc), a subtype of SSc, a phase II proof-of-concept study has shown.

Romilkimab shows potential for early diffuse cutaneous systemic sclerosis

22 Jan 2021

Acute flares do not last long on febuxostat

21 Jan 2021

In patients with gout, treatment with febuxostat does not appear to prolong the duration of acute flares, a study has shown.

Acute flares do not last long on febuxostat

21 Jan 2021

Flat flexible vs stable supportive shoes: which is better at reducing knee OA symptoms?

18 Jan 2021

Flat flexible shoes do not appear to be better than stable supportive shoes for patients with knee osteoarthritis (OA) symptoms, according to a study.

Flat flexible vs stable supportive shoes: which is better at reducing knee OA symptoms?

18 Jan 2021

Vitamin D plus protein helps strengthen but not bulk up muscle in sarcopenia

16 Jan 2021

In patients with sarcopenia, vitamin D supplementation in combination with protein increases muscle strength but falls short of improving muscle mass or performance, according to the results of a systematic review and meta-analysis.

Vitamin D plus protein helps strengthen but not bulk up muscle in sarcopenia

16 Jan 2021

TNFi plus csDMARD does not improve disease activity, HAQ in psoriatic arthritis

16 Jan 2021

Tumour necrosis factor inhibitor (TNFi) in combination with conventional synthetic disease-modifying antirheumatic drugs (csDMARD) does not appear to be any better than TNFi monotherapy at improving disease activity or Health Assessment Questionnaire (HAQ) in patients with psoriatic arthritis (PsA), reports a study. However, the combination therapy may improve TNFi survival.

TNFi plus csDMARD does not improve disease activity, HAQ in psoriatic arthritis

16 Jan 2021

Patients with ankylosing spondylitis at risk of hearing loss

15 Jan 2021

The likelihood of having hearing loss (HL) is higher among patients with ankylosing spondylitis (AS) than those without, according to a new study.

Patients with ankylosing spondylitis at risk of hearing loss

15 Jan 2021

Bariatric surgery could be indicated for gout in obese individuals

13 Jan 2021

Bariatric surgery successfully lowers weight and serum uric acid (SUA) in obese patients with hyperuricaemia and gout, a study reports.

Bariatric surgery could be indicated for gout in obese individuals

13 Jan 2021

$SGLT2 inhibitors do not pose fracture risk$

SGLT2 inhibitors do not pose fracture risk

09 Jan 2021

The use of sodium-glucose cotransporter 2 inhibitors (SGLT2i), either alone or in combination with other glucose-lowering medications (GLM), does not seem to exacerbate the risk of sustaining fractures, a new study has found.

SGLT2 inhibitors do not pose fracture risk

09 Jan 2021

News & Updates

Filter by Specialty:

Specialty:

Amiselimod exhibits favourable safety in healthy individuals

Amiselimod exhibits favourable safety in healthy individuals

Sexual problems in men with ankylosing spondylitis tied to disease activity

Sexual problems in men with ankylosing spondylitis tied to disease activity

Romilkimab shows potential for early diffuse cutaneous systemic sclerosis

Romilkimab shows potential for early diffuse cutaneous systemic sclerosis

Acute flares do not last long on febuxostat

Acute flares do not last long on febuxostat

Flat flexible vs stable supportive shoes: which is better at reducing knee OA symptoms?

Flat flexible vs stable supportive shoes: which is better at reducing knee OA symptoms?

Vitamin D plus protein helps strengthen but not bulk up muscle in sarcopenia

Vitamin D plus protein helps strengthen but not bulk up muscle in sarcopenia

TNFi plus csDMARD does not improve disease activity, HAQ in psoriatic arthritis

TNFi plus csDMARD does not improve disease activity, HAQ in psoriatic arthritis

Patients with ankylosing spondylitis at risk of hearing loss

Patients with ankylosing spondylitis at risk of hearing loss

Bariatric surgery could be indicated for gout in obese individuals

Bariatric surgery could be indicated for gout in obese individuals

SGLT2 inhibitors do not pose fracture risk

SGLT2 inhibitors do not pose fracture risk